124 related articles for article (PubMed ID: 27067437)
1. The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.
Yıldırım ME; Kefeli U; Aydın D; Sener N; Gümüş M
Tumour Biol; 2016 Sep; 37(9):11903-11907. PubMed ID: 27067437
[TBL] [Abstract][Full Text] [Related]
2. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment.
Kefeli U; Yildirim ME; Aydin D; Madenci OC; Yasar N; Sener N; Mert AG; Yuksel S; Ercelep OB; Korkmaz T; Yildiz R; Gumus M
Biomarkers; 2012 Nov; 17(7):663-7. PubMed ID: 22889408
[TBL] [Abstract][Full Text] [Related]
3. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Yu LK; Zhang X
Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
5. The value of serum Bcl-2 levels in advanced lung cancer patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
[TBL] [Abstract][Full Text] [Related]
7. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
8. Plasma netrin-1 is a diagnostic biomarker of human cancers.
Ramesh G; Berg A; Jayakumar C
Biomarkers; 2011 Mar; 16(2):172-80. PubMed ID: 21303223
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
12. CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.
Sone K; Oguri T; Nakao M; Kagawa Y; Kurowaka R; Furuta H; Fukuda S; Uemura T; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Maeno K; Ito Y; Sato H; Muramatsu H; Niimi A
Anticancer Res; 2017 Feb; 37(2):935-939. PubMed ID: 28179355
[TBL] [Abstract][Full Text] [Related]
13. Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jun; 36(6):4253-60. PubMed ID: 25578497
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
15. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic value of serum periostin in advanced non-small cell lung cancer patients receiving chemotherapy.
Zhang Y; Yuan D; Yao Y; Sun W; Shi Y; Su X
Tumour Biol; 2017 May; 39(5):1010428317698367. PubMed ID: 28459197
[TBL] [Abstract][Full Text] [Related]
17. Plasma netrin-1 levels significantly increase in smokers.
Kızmaz M; Marakoğlu K; Kıyıcı A; Ay E
Clin Biochem; 2016 Jul; 49(10-11):832-4. PubMed ID: 26944719
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of serum p53 antibodies in lung cancer.
Mattioni M; Soddu S; Prodosmo A; Visca P; Conti S; Alessandrini G; Facciolo F; Strigari L
BMC Cancer; 2015 Mar; 15():148. PubMed ID: 25884692
[TBL] [Abstract][Full Text] [Related]
19. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.
Nygaard AD; Garm Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
Lung Cancer; 2013 Mar; 79(3):312-7. PubMed ID: 23238036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
